AAA | No AAA | p | |
---|---|---|---|
(n = 19) | (n = 191) | ||
Age (years) | 71.2 ± 7.0 | 65.4 ± 9.9 | 0.015 |
Age ≥ 65 years | 16 (84.2) | 110 (57.6) | 0.024 |
Males | 17 (89.5) | 152 (79.6) | 0.300 |
Risk factors | |||
Smoking | 18 (94.7) | 170 (89.0) | 0.437 |
Hypertension | 18 (94.7) | 136 (71.2) | 0.027 |
Hypercholesterolemia | 15 (78.9) | 122 (63.9) | 0.188 |
Diabetes Mellitus | 4 (21.1) | 71 (37.2) | 0.162 |
BMI (kg/m2) | 26.5 ± 3.7 | 26.2 ± 3.4 | 0.742 |
WC (cm) | 96.7 ± 9.6 | 97.7 ± 9.4 | 0.708 |
Metabolic syndrome | 9 (47.4) | 87 (45.5) | 0.879 |
Comorbidity | |||
CAD | 10 (52.6) | 96 (50.3) | 0.844 |
Previous MI | 5 (26.3) | 71 (37.2) | 0.348 |
Previous stroke | 1 (5.2) | 7 (3.7) | 0.729 |
Medications | |||
Antiplatelets | 18 (94.7) | 173 (90.6) | 0.547 |
Beta blockers | 2 (10.5) | 45 (23.6) | 0.194 |
ACE-inhibitors | 11 (57.9) | 93 (48.7) | 0.444 |
Statins | 10 (52.6) | 120 (62.8) | 0.383 |
Carotid status | |||
Carotid stenosis >50% | 9 (47.4) | 56 (29.3) | 0.105 |
LE-PAD severity | |||
Bilateral LE-PAD | 13 (68.4) | 118 (61.8) | 0.569 |
ABI | 0.64 ± 0.11 | 0.69 ± 0.23 | 0.315 |
Inflammatory status | |||
Neutrophil count (x103/μL) | 5.5 [4.5 – 6.2] | 4.1 [3.2 – 5.5] | 0.010 |